Prenetics Global Limited
NASDAQ:PREMedical - Diagnostics & Research
Healthcare
$10.31 +2.19%
+$0.43 today
- Market cap
- $184.89M
- Beta
- 0.24
- P/E (TTM)
- -4.9
- EPS (TTM)
- -$4.18
52W Low $7.18High $23.63
Volume 0.82M
Average 0.22M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$21.81M
FY 2025 · Annual
Investing Cash Flow
-$35.79M
FY 2025 · Annual
Financing Cash Flow
$37.54M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (174.02M) | (190.45M) | (64.78M) | (49.81M) | (52.7M) |
| Depreciation & Amortization | 7.35M | 7.54M | 7.79M | 5.93M | 3.78M |
| Deferred Income Tax | 3.73M | 7.15M | (385.84K) | (7.87M) | 0 |
| Stock-Based Compensation | 22.49M | 31.58M | 10.59M | 11.98M | 0 |
| Change in Working Capital | (6.59M) | (33.76M) | 24.21M | 1.97M | 6.62M |
| Accounts Receivables | (24.06M) | 6.97M | 37.63M | (428K) | (529K) |
| Inventory | (2.33M) | 1.26M | (1.73M) | 1.32M | (3.38M) |
| Accounts Payables | (3.46M) | (2.63M) | (5.62M) | (4.68M) | 4.91M |
| Other Working Capital | 23.26M | (39.36M) | (6.08M) | 5.75M | 5.62M |
| Other Non-Cash Items | 160.45M | 192.46M | 8.8M | 8.93M | 20.48M |
| Operating Cash Flow | 13.42M | 14.51M | (13.76M) | (28.87M) | (21.81M) |
| Capital Expenditures | (11.41M) | (6.34M) | (911.81K) | (1.07M) | (208K) |
| Acquisitions (Net) | 0 | (3.42M) | 0 | 21.65M | 37.78M |
| Purchases of Investments | (10M) | (39.92M) | (26M) | (129K) | (20M) |
| Sales of Investments | 0 | 3M | 19.92M | 16M | 0 |
| Other Investing Activities | (3.47M) | 531.99K | (76.52M) | 2.02M | 1,000K |
| Investing Cash Flow | (22.02M) | (46.14M) | (82.95M) | 38.54M | (35.79M) |
| Debt Repayment | (1.3M) | (1.88M) | (3.23M) | (2.56M) | 40.15M |
| Common Stock Issued | 0 | 116.86K | 2.17K | 0 | 2K |
| Common Stock Repurchased | 0 | (661.52K) | (1.23M) | (577K) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 4.65M | 145.86M | (241.5K) | (203K) | (2.61M) |
| Financing Cash Flow | 29.32M | 143.32M | (4.7M) | (3.34M) | 37.54M |
| Effect of Forex Changes | 87.21K | (317.47K) | 467.93K | 221K | (65K) |
| Net Change in Cash | 20.8M | 111.37M | (100.95M) | 6.55M | (20.12M) |
| Free Cash Flow | 2M | 8.17M | (14.68M) | (29.94M) | (22.02M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$52.7M
+ D&A$3.8M
+ Stock-Based Comp$0
+ Deferred Tax$0
+ Working Capital$6.6M
+ Other Non-Cash$20.5M
= Operating Cash Flow-$21.8M
- Capex-$208.0K
= Free Cash Flow-$22.0M
Analysis
FY2025 free cash flow is -$22.0M. FCF conversion is 41.8% of net income. Operating cash flow was -$21.8M, with capex of -$208.0K. The largest bridge item is Other Non-Cash at $20.5M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 6-K | 6-K filing | Nov 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 5, 2026 | |
| 6-K | 6-K filing | Nov 3, 2026 | |
| 6-K | 6-K filing | Nov 2, 2026 | |
| 6-K | 6-K filing | Oct 13, 2026 |
Does PRE generate free cash flow?
Prenetics Global Limited (PRE) generated -$22.02M of free cash flow in fiscal 2025.
How much operating cash flow does PRE produce?
Operating cash flow was -$21.81M, before capital expenditures of $208,000.00.
Continue the stock analysis
Jump to another research area for this company.